Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Arthritis & Rheumatism

• Publication date

  1988-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.1780311201PMID 3196364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.

  2009cited by this paper
• Liver ultrastructure in psoriatics related to methotrexate therapy. 1. A prospective study of findings in hepatocytes from 24 patients before and after methotrexate treatment.

  2009cited by this paper
• Methotrexate in rheumatoid arthritis.

  1988cited by this paper
• Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial.

  1987cited by this paper
• The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.

  1986cited by this paper
• Low-dose methotrexate in rheumatoid arthritis: effect and tolerance. An open trial and a double-blind randomized study.

  1986cited by this paper
• Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations.

  1985cited by this paper
• Methotrexate and the liver.

  1985cited by this paper
• Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

  1985cited by this paper
• Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.

  1985cited by this paper
• Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis

  1985cited by this paper
• Mineral oil lipogranulomata in liver and spleen. A study of 465 autopsies.

  1985cited by this paper
• Efficacy of low-dose methotrexate in rheumatoid arthritis.

  1985cited by this paper
• Mineral oil lipogranulomata in liver and spleen. A study of 465 autopsies.

  1985cited by this paper
• Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis.

  1985cited by this paper
• A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.

  1984cited by this paper
• Methotrexate therapy in rheumatoid arthritis: 15 years experience.

  1983cited by this paper
• Toxicity from methotrexate may be dose related.

  1983cited by this paper
• Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature.

  1983cited by this paper
• Methotrexate guidelines--revised.

  1982cited by this paper
• Weekly intravenous methotrexate in the treatment of rheumatoid arthritis.

  1982cited by this paper
• Low dose methotrexate in rheumatoid arthritis.

  1982cited by this paper
• Methotrexate: a perspective of its use in the treatment of rheumatic diseases.

  1982cited by this paper
• Low dose pulse methotrexate therapy in rheumatoid arthritis.

  1980cited by this paper
• Methotrexate in the treatment of rheumatoid arthritis; pilot study.

  1980cited by this paper
• Low dose pulse methotrexate therapy in rheumatoid arthritis.

  1980cited by this paper
• Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.

  1976cited by this paper
• Liver biopsy in methotrexate-treated psoriatics-a re-evalution.

  1975cited by this paper
• Liver disease in psoriatics--An effect of methotrexate therapy?

  1974cited by this paper
• Psoriasis-liver-methotrexate interactions.

  1973cited by this paper
• Liver injury associated with methotrexate therapy for psoriasis.

  1973cited by this paper
• Methotrexate Hepatotoxicity in Psoriasis—Comparison of Different Dose Regimens

  1972cited by this paper
• Liver Damage due to Methotrexate in Patients with Psoriasis

  1971cited by this paper
• Pulmonary and hepatic complications of methotrexate therapy of psoriasis.

  1971cited by this paper
• The anti‐inflammatory effect of some immunosuppressive agents

  1969cited by this paper
• Cirrhosis following methotrexate administration for psoriasis.

  1969cited by this paper
• Cirrhosis associated with methotrexate treatment of psoriasis.

  1968cited by this paper
• Methotrexate for psoriasis. A preliminary report.

  1965cited by this paper
• METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS.

  1964cited by this paper
• 1958 Revision of diagnostic criteria for rheumatoid arthritis.

  1959cited by this paper
• Treatment of psoriasis with folic acid antagonists.

  1958cited by this paper
• One-second needle biopsy of the liver.

  1958cited by this paper
• THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITY: I. Comparison of the Effects of Cortisone and Aminopterin

  1951cited by this paper

• Normas

  2020cites this paper
• "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?"

  2019cites this paper
• Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study.

  2017cites this paper
• Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease

  2017cites this paper
• Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B

  2016cites this paper
• Histopathological Evaluation of Drug-Induced Liver Disease

  2013cites this paper
• Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.

  2013cites this paper
• Methotrexate in Rheumatoid Arthritis

  2012cites this paper
• Prognosis in the Rheumatic Diseases

  2012cites this paper
• A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs

  2012cites this paper
• Methotrexate: from its introduction to non-oncologic therapeutics to anti-TNF-α.

  2010cites this paper
• Methotrexate: from its introduction to non-oncologic therapeutics to anti-TNF-α.

  2010cites this paper
• Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature.

  2009cites this paper
• Evidence-Based Recommendations of a National Group of Experts on the Use of Methotrexate in Infl ammatory Rheumatic Diseases

  2009cites this paper
• Drug-induced liver injury: is it somehow foreseeable?

  2009cites this paper
• [The network of methotrexate toxicity].

  2009cites this paper
• [The liver and methotrexate].

  2008cites this paper
• Foie et méthotrexate

  2008cites this paper
• Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

  2008cites this paper
• Fatty liver and transaminase changes with adjuvant tamoxifen therapy

  2006cites this paper
• Dose-dependent Pharmacokinetics of Methotrexate and 7-Hydroxymethotrexate in the Rat in Vivo1

  2006cites this paper
• A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy

  2004cites this paper
• Benefit and risk of methotrexate treatment in rheumatoid arthritis.

  2004cites this paper
• Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis

  2004cites this paper
• Association of Primary Biliary Cirrhosis and Rheumatoid Arthritis

  2003cites this paper
• Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.

  2002cites this paper
• Management of rheumatoid arthritis: the historical context.

  2001cites this paper
• Efficacy of interferon‐α2b treatment in children with chronic hepatitis B who have previously undergone therapy for cancer

  2000cites this paper
• Methotrexate use in rheumatoid arthritis. A Clinician's perspective.

  2000cites this paper
• Methotrexate hepatotoxicity: What is the evidence?

  1998cites this paper
• Methotrexate hepatotoxicity.

  1997cites this paper
• The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis.

  1997cites this paper
• Methotrexate in Rheumatoid Arthritis

  1997cites this paper
• Methotrexate in Rheumatoid Arthritis

  1997cites this paper
• Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease.

  1996cites this paper
• Problems with pain--is the messenger to blame?

  1996cites this paper
• Liver biopsy findings in patients with juvenile rheumatoid arthritis receiving long-term, weekly methotrexate therapy.

  1996cites this paper
• Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists.

  1996cites this paper
• Review article: methotrexate in gastroenterology—dangerous villain or simply misunderstood?

  1996cites this paper
• Experience with low-dose methotrexate: Toxicity, tolerability and effect on conventional patterns of drug therapy for inflammatory arthritis

  1995cites this paper
• The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate.

  1995cites this paper
• Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients.

  1995cites this paper
• Rheumatoid arthritis: new approaches for its evaluation and management.

  1995cites this paper
• Methotrexate in rheumatoid arthritis. An update.

  1994cites this paper
• Methotrexate for Rheumatoid Arthritis

  1994cites this paper
• Patient's preference regarding the option of performing unselective liver biopsy following methotrexate treatment in rheumatoid arthritis.

  1994cites this paper
• A Risk-Benefit Assessment of Slow-Acting Antirheumatic Drugs in Rheumatoid Arthritis

  1994cites this paper
• Methotrexate: adverse reactions and major toxicities.

  1994cites this paper
• [Side effects and efficiency of 15 mg and 25 mg methotrexate per week in chronic polyarthritis].

  1994cites this paper
• Guidelines for routine liver biopsy during methotrexate treatment.

  1994cites this paper
• Second-line drug therapy for rheumatoid arthritis.

  1994cites this paper
• [Treatment of chronic polyarthritis with methotrexate 1994--a review].

  1994cites this paper
• Low-dose methotrexate in rheumatic diseases--efficacy, side effects, and risk factors for side effects.

  1994cites this paper
• Methotrexate: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Rheumatoid Arthritis and Other Immunoregulatory Disorders

  1994cites this paper
• The use of suppressive agents for the treatment of rheumatoid arthritis.

  1993cites this paper
• Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?

  1993cites this paper
• Juvenile Rheumatoid Arthritis

  1993cites this paper
• [Therapy of rheumatoid arthritis with azathioprine--results of an open long-term study of at least 4 years with 528 patients].

  1993cites this paper
• [Rheumatoid arthritis. Therapeutic efficacy of methotrexate and its hepatotoxic effects].

  1993cites this paper
• Symposium in Immunology I and II

  1993cites this paper
• Biomedical Research and Changing Concepts of Disease and Aging: Implications for Long-Term Health Forecasts for Elderly Populations

  1993cites this paper
• Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.

  1993cites this paper
• Genetic and acquired factors that influence individual susceptibility to alcohol‐associated liver disease

  1992cites this paper
• A debate: should patients with rheumatoid arthritis on methotrexate undergo liver biopsies?

  1992cites this paper
• Liver enzyme levels in arthritis patients treated with long-term bolus methotrexate.

  1992cites this paper
• Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update.

  1992cites this paper
• Pharmacological Management of Juvenile Rheumatoid Arthritis

  1992cites this paper
• Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going?

  1992cites this paper
• Pharmacology of antiarthritic drugs.

  1992cites this paper
• Remission induction in rheumatoid arthritis.

  1992cites this paper
• Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months.

  1992cites this paper
• Long-term methotrexate therapy for rheumatoid arthritis.

  1991cites this paper
• [Methotrexate in rheumatoid arthritis].

  1991cites this paper
• Effect of folinic acid on tissue residence and excretion of methotrexate in rats.

  1991cites this paper
• Methotrexate and histologic hepatic abnormalities: a meta-analysis.

  1991cites this paper
• Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.

  1991cites this paper
• Prediction of organ system toxicity with antirheumatic drug therapy

  1991cites this paper
• Promises and Problems with the Use of Methotrexate in the Asthmatic Patient

  1991cites this paper
• Hepatotoxicity in a rat model caused by orally administered methotrexate

  1991cites this paper
• Hepatic fibrosis with the use of methotrexate for juvenile rheumatoid arthritis.

  1990cites this paper
• Parenteral methotrexate or gold for rheumatoid arthritis: a follow up.

  1990cites this paper
• USE OF METHOTREXATE FOR REFRACTORY INFLAMMATORY BOWEL DISEASE

  1990cites this paper
• Safety and efficacy therapy for juvenile of methotrexate rheumatoid arthritis

  1990cites this paper
• Methotrexate hepatotoxicity and the premature reporting of Mark Twain's death: Both greatly exaggerated

  1990cites this paper
• Risk factors of second-line antirheumatic drugs in rheumatoid arthritis.

  1990cites this paper
• Resolve: methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis.

  1990cites this paper
• [Methotrexate. Pharmacology applied to the treatment of rheumatoid arthritis].

  1990cites this paper
• Inflammatory Bowel Diseases 1990

  1990cites this paper
• Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up

  1990influential citation
• The cycling of combination antirheumatic drug therapy in rheumatoid arthritis.

  1990cites this paper
• Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.

  1990cites this paper
• Effects of oxygen inhalation in ascitic cirrhotic patients: Therapeutic implications?

  1990cites this paper
• Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis.

  1990cites this paper
• Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis.

  1990cites this paper
• Methotrexate--the rapidly acting drug.

  1990cites this paper
• The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis.

  1990cites this paper
• METHOTREXATE‐ITS CURRENT USE IN RHEUMATOID ARTHRITIS

  1989cites this paper
• Electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis. Correlation with light microscopic findings.

  1989cites this paper
• Methotrexate-induced liver abnormalities in rheumatoid arthritis.

  1989cites this paper
• Methotrexate 1989--the evolving story.

  1989cites this paper